Se ha denunciado esta presentación.
Utilizamos tu perfil de LinkedIn y tus datos de actividad para personalizar los anuncios y mostrarte publicidad más relevante. Puedes cambiar tus preferencias de publicidad en cualquier momento.
Matti Ristimäki
Vice President, Data-driven business
Healthcare bigdata
accelerating algorithm
development for
personalize...
TIME-TO-DATA
@mattiristimaki
Data-driven
organisation
Traditional
organisation
ICT ICT ICT ICT
Data Platform
= Healthcare service= Patient
@mattiristim...
DATA
CHALLENGE
@mattiristimaki
Data scattered in
various systems
Unstructured
text data
Confidential
privacy data
Data bias –
only data
from sick people
...
BIG DATA
PLATFORM FOR
HEALTHCARE
@mattiristimaki
Helsinki University Hospital
University of Helsinki
Engaged citizens
Virtual hospital
Partners:
CleverHealth Network
Pharm...
Clinical-analytics
Advance AI
development
University’s
research
Partner’s
product
development
AGILE
AI DEV
Research
sandbo...
RESEARCH AND ANALYTICS SUPPORT OPERATIVE AND CLINICAL EXCELLENCE
SELF-SERVICE ANALYTICS AND DATA APPLICATIONS
@mattiristim...
EXAMPLES
@mattiristimaki
Optimaalisuus
ECARE FOR ME – NEXT GENERATION ALGORITHM
RESEARCH FOR SPECIAL CARE
@mattiristimaki
In Finland 6000 different rare diseases
~6% citizens, ~18% of special care cost
Waste of resources is significant
Lähde: H...
EXAMPLE 2: ACUTE LEUKEMIA
@mattiristimaki
Treatment is highly toxic;
treatment-related mortality
(TRM) is 10-30%
< 50% of ...
@mattiristimaki
Próxima SlideShare
Cargando en…5
×

Ristimaki presentation VTT SmartHealth Ecosystem Event 12.6.2019

87 visualizaciones

Publicado el

SmartHealth Ecosystem Event 12.6.2019, Matti Ristimäki presentation on Healthcare bigdata - accelerating algorithm development for personalized medicine

Publicado en: Tecnología
  • Sé el primero en comentar

  • Sé el primero en recomendar esto

Ristimaki presentation VTT SmartHealth Ecosystem Event 12.6.2019

  1. 1. Matti Ristimäki Vice President, Data-driven business Healthcare bigdata accelerating algorithm development for personalized medicine From reactive organizations to preventive and individually centric ones @mattiristimaki
  2. 2. TIME-TO-DATA @mattiristimaki
  3. 3. Data-driven organisation Traditional organisation ICT ICT ICT ICT Data Platform = Healthcare service= Patient @mattiristimaki
  4. 4. DATA CHALLENGE @mattiristimaki
  5. 5. Data scattered in various systems Unstructured text data Confidential privacy data Data bias – only data from sick people Lack of efficient data models @mattiristimaki
  6. 6. BIG DATA PLATFORM FOR HEALTHCARE @mattiristimaki
  7. 7. Helsinki University Hospital University of Helsinki Engaged citizens Virtual hospital Partners: CleverHealth Network Pharma Companies Quality registers National registries HR Research databases Patient journals (EMR) Financials / Cost per patient Radiology Genome Acute care monitors / Medical devices Service usage Laboratory Pathology Imaging Personal wellbeing gadgets CASE HELSINKI UNIVERSITY HOSPITAL DATA PLATFORM Time to data Data platform Biobank @mattiristimaki
  8. 8. Clinical-analytics Advance AI development University’s research Partner’s product development AGILE AI DEV Research sandbox Research Sandbox Research Sandbox Cancer center side platform Biobank Side platform X Side platform AI applications Processes Data in HUS DATA PLATFORM HUS data team Tieto platform team @mattiristimaki
  9. 9. RESEARCH AND ANALYTICS SUPPORT OPERATIVE AND CLINICAL EXCELLENCE SELF-SERVICE ANALYTICS AND DATA APPLICATIONS @mattiristimaki
  10. 10. EXAMPLES @mattiristimaki
  11. 11. Optimaalisuus ECARE FOR ME – NEXT GENERATION ALGORITHM RESEARCH FOR SPECIAL CARE @mattiristimaki
  12. 12. In Finland 6000 different rare diseases ~6% citizens, ~18% of special care cost Waste of resources is significant Lähde: HUS Harvinaisten sairauksien toimintayksikön vuosikertomus Cost 80% of time 20% of cost 80% of cost 20% of time Time EXAMPLE 1: RARE DISEASES @mattiristimaki
  13. 13. EXAMPLE 2: ACUTE LEUKEMIA @mattiristimaki Treatment is highly toxic; treatment-related mortality (TRM) is 10-30% < 50% of patients benefit from therapy, all are exposed to toxicity and TRM Millions of data points per patient available
  14. 14. @mattiristimaki

×